ANI Pharmaceuticals Inc (ANIP)
64.90
+1.44
(+2.27%)
USD |
NASDAQ |
May 31, 16:00
64.95
+0.05
(+0.08%)
After-Hours: 20:00
ANI Pharmaceuticals Market Cap: 1.360B for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.360B |
| May 30, 2024 | 1.330B |
| May 29, 2024 | 1.322B |
| May 28, 2024 | 1.325B |
| May 24, 2024 | 1.285B |
| May 23, 2024 | 1.265B |
| May 22, 2024 | 1.292B |
| May 21, 2024 | 1.294B |
| May 20, 2024 | 1.294B |
| May 17, 2024 | 1.288B |
| May 16, 2024 | 1.337B |
| May 15, 2024 | 1.359B |
| May 14, 2024 | 1.384B |
| May 13, 2024 | 1.412B |
| May 10, 2024 | 1.426B |
| May 09, 2024 | 1.381B |
| May 08, 2024 | 1.376B |
| May 07, 2024 | 1.399B |
| May 06, 2024 | 1.412B |
| May 03, 2024 | 1.410B |
| May 02, 2024 | 1.408B |
| May 01, 2024 | 1.396B |
| April 30, 2024 | 1.385B |
| April 29, 2024 | 1.374B |
| April 26, 2024 | 1.371B |
| Date | Value |
|---|---|
| April 25, 2024 | 1.363B |
| April 24, 2024 | 1.373B |
| April 23, 2024 | 1.388B |
| April 22, 2024 | 1.377B |
| April 19, 2024 | 1.374B |
| April 18, 2024 | 1.355B |
| April 17, 2024 | 1.374B |
| April 16, 2024 | 1.375B |
| April 15, 2024 | 1.391B |
| April 12, 2024 | 1.403B |
| April 11, 2024 | 1.429B |
| April 10, 2024 | 1.405B |
| April 09, 2024 | 1.407B |
| April 08, 2024 | 1.418B |
| April 05, 2024 | 1.419B |
| April 04, 2024 | 1.425B |
| April 03, 2024 | 1.411B |
| April 02, 2024 | 1.400B |
| April 01, 2024 | 1.424B |
| March 28, 2024 | 1.450B |
| March 27, 2024 | 1.462B |
| March 26, 2024 | 1.460B |
| March 25, 2024 | 1.461B |
| March 22, 2024 | 1.461B |
| March 21, 2024 | 1.456B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
292.51M
Minimum
Nov 06 2020
1.462B
Maximum
Mar 27 2024
704.70M
Average
664.47M
Median
Dec 16 2022
Market Cap Benchmarks
| Ligand Pharmaceuticals Inc | 1.530B |
| ADMA Biologics Inc | 2.214B |
| Annovis Bio Inc | 73.17M |
| United Therapeutics Corp | 12.22B |
| Moderna Inc | 54.63B |
Market Cap Related Metrics
| PE Ratio | 41.08 |
| PS Ratio | 2.374 |
| Price to Book Value | 3.01 |
| Price to Free Cash Flow | 12.92 |
| Price | 64.90 |
| Earnings Yield | 2.43% |
| Operating PE Ratio | 23.35 |
| Normalized PE Ratio | 62.42 |